Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AFC HD AMS Life Science Co's other current liabilities for the quarter that ended in Feb. 2026 was 円3,782 Mil.
AFC HD AMS Life Science Co's quarterly other current liabilities
increased
from Feb. 2025 (円3,253 Mil) to Aug. 2025 (円3,456 Mil) and
increased
from Aug. 2025 (円3,456 Mil) to Feb. 2026 (円3,782 Mil).
AFC HD AMS Life Science Co's annual other current liabilities
increased
from Aug. 2023 (円3,003 Mil) to Aug. 2024 (円3,931 Mil) but then
declined
from Aug. 2024 (円3,931 Mil) to Aug. 2025 (円3,456 Mil).
AFC HD AMS Life Science Co Other Current Liabilities Related Terms
AFC HD AMS Life Science Co Other Current Liabilities Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AFC HD AMS Life Science Co Other Current Liabilities Chart
AFC HD AMS Life Science Co Other Current Liabilities Calculation
The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.
What does a Other Current Liabilities of 円3,782 Mil mean?
AFC HD AMS Life Science Co (TSE:2927) has a Other Current Liabilities of 円3,782 Mil as of Feb. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on AFC HD AMS Life Science Co.
Is AFC HD AMS Life Science Co's Other Current Liabilities too high?
AFC HD AMS Life Science Co's current Other Current Liabilities is 円3,782 Mil. Overall, AFC HD AMS Life Science Co has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AFC HD AMS Life Science Co's Other Current Liabilities compare to KHC and GIS?
AFC HD AMS Life Science Co's Other Current Liabilities of 円3,782 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Consumer Packaged Goods company?
A good Other Current Liabilities depends on the Consumer Packaged Goods industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on AFC HD AMS Life Science Co. AFC HD AMS Life Science Co's current Other Current Liabilities is 円3,782 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AFC HD AMS Life Science Co stock overvalued right now?
Based on GuruFocus' analysis, AFC HD AMS Life Science Co (TSE:2927) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,003.23, compared to a current price of 円866.00 — trading 13.7% below its estimated fair value. The current Other Current Liabilities is 円3,782 Mil. AFC HD AMS Life Science Co's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For AFC HD AMS Life Science Co (TSE:2927), the current Other Current Liabilities is 円3,782 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AFC HD AMS Life Science Co (TSE:2927) Overvalued in 2026?
Based on GuruFocus' analysis, AFC HD AMS Life Science Co stock appears to be undervalued.
The current stock price of 円866.00 is trading 13.7% below its estimated GF Value™ of 円1,003.23.
GuruFocus considers AFC HD AMS Life Science Co to be Modestly Undervalued.
Key valuation signals for TSE:2927:
Other Current Liabilities: 円3,782 Mil
GF Value™: 円1,003.23 vs. price of 円866.00 (13.7% below fair value)
No single metric tells the full story. See the TSE:2927 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2927 has been successfully added to your 
